Docoh
Loading...

RIGL Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Company profile

Ticker
RIGL
Exchange
Website
CEO
Raul Rodriguez
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
943248524

RIGL stock data

(
)

Calendar

2 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 30.37M 30.37M 30.37M 30.37M 30.37M 30.37M
Cash burn (monthly) 2.06M (positive/no burn) 6.28M 2.41M 5.19M 4.35M
Cash used (since last report) 7.11M n/a 21.6M 8.31M 17.87M 14.97M
Cash remaining 23.27M n/a 8.77M 22.06M 12.51M 15.41M
Runway (months of cash) 11.3 n/a 1.4 9.1 2.4 3.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Apr 21 Raul R Rodriguez Stock Option Common Stock Grant Aquire A No No 2.42 162,500 393.25K 162,500
1 Apr 21 Dean L Schorno Stock Option Common Stock Grant Aquire A No No 2.42 50,000 121K 50,000
1 Apr 21 Dolly Vance Stock Option Common Stock Grant Aquire A No No 2.42 37,500 90.75K 37,500
27 Jan 21 Raul R Rodriguez Stock Option(right to buy) Common Stock Grant Aquire A No No 3.54 525,000 1.86M 525,000
27 Jan 21 Dolly Vance Stock Option(right to buy) Common Stock Grant Aquire A No No 3.54 125,000 442.5K 125,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

82.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 150 141 +6.4%
Opened positions 24 25 -4.0%
Closed positions 15 19 -21.1%
Increased positions 42 36 +16.7%
Reduced positions 52 50 +4.0%
13F shares
Current Prev Q Change
Total value 1.07B 1.02B +5.0%
Total shares 140.57M 139.77M +0.6%
Total puts 483.1K 670.3K -27.9%
Total calls 613.7K 374.3K +64.0%
Total put/call ratio 0.8 1.8 -56.0%
Largest owners
Shares Value Change
FMR 20.91M $73.2M -1.4%
BLK Blackrock 17.49M $61.23M +1.7%
Wellington Management 11.2M $39.2M -18.4%
STT State Street 9.36M $32.77M -7.4%
Vanguard 9.15M $32.01M +2.7%
Tamarack Advisers 7.45M $25.96M -0.7%
Citadel Advisors 6.34M $22.19M +1.3%
MS Morgan Stanley 5.23M $18.29M +80.4%
IVZ Invesco 5.13M $17.94M +2.3%
Rock Springs Capital Management 4.74M $16.6M 0.0%
Largest transactions
Shares Bought/sold Change
Wellington Management 11.2M -2.52M -18.4%
MS Morgan Stanley 5.23M +2.33M +80.4%
GS Goldman Sachs 2.9M +1.97M +211.4%
Ion Asset Management 1.83M +1.83M NEW
Renaissance Technologies 2.09M -1.29M -38.2%
Acadian Asset Management 169.64K -1.04M -85.9%
Integrated Core Strategies 1.03M +1.03M NEW
STT State Street 9.36M -743.84K -7.4%
J. Goldman & Co 101.04K -741.45K -88.0%
AIGH Capital Management 701.7K +701.7K NEW

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: absenteeism, abundance, accessed, accessibility, accuracy, activist, adapt, adaptive, adequacy, advocacy, advocating, afflicted, AgreementSM, Alabama, ALI, alleviating, anesthesiologist, Antitrust, arm, ascertain, ASCO, barrier, Biden, biomarker, Biovitrum, Birmingham, border, brain, Brazil, breakdown, Britain, British, burdensome, cap, career, CCPA, cessation, Chemical, cITP, CJEU, closure, CLR, CMT, CNS, College, commerce, Commissioner, Condensed, confidence, conflicting, Consortium, constitutionality, contemplated, conventional, costliest, COVID, CPRA, CTR, cybersecurity, David, deceptive, deny, depletion, deploy, deployed, deprive, Digital, distancing, diverge, divergent, DOD, donor, draft, dysfunction, Ebola, edema, EEA, Eli, embedded, endeavor, endothelial, England, enveloped, epithelial, ESG, evolution, expedited, extracellular, fast, faster, fined, Foundation, France, fundamentally, gamma, GBM, GDPR, Genentech, Germany, glioblastoma, Great, Haematology, harbor, Harvard, Heart, highlighting, home, HSR, hyperinflammation, hyperinflammatory, Ichiro, IgG, ill, impede, Imperial, inclusion, India, infection, inflation, Inline, Inova, interference, Interferon, Internationally, ion, Ireland, Italy, Jazz, join, jointly, Justice, KeytrudaTM, landscape, League, leave, lectin, led, Lilly, live, macrophage, macrovascular, magnitude, matched, mediated, MHRA, micro, misrepresentative, misuse, MIT, mortality, movement, myocardial, Nakano, narrowed, nation, national, nationwide, necessitate, Neurosurgery, neutrophil, NHS, NIH, NOL, Nuclear, nurse, opportunistic, opportunistically, opposition, parallel, partnership, pathology, pause, paused, penetrating, perspective, PFS, pneumonia, poor, poster, preferential, presidential, Professor, prognostic, prolonged, pulmonary, pursuit, qualification, Radiological, Rain, randomly, recession, recurrent, redacted, reexamining, refill, regularly, remote, remotely, repayable, repurposing, resection, residence, residency, residing, respiratory, retention, revised, Rheumatism, RIP, risky, rulemaking, ruxolitinib, SAE, salesforce, Scotland, Scottish, sequester, serum, Shareholder, shelter, Shield, ship, shipping, shock, shop, simply, slowdown, SOC, software, Southampton, Spain, speaker, speculative, store, substance, supervisory, Supreme, surface, surge, surgical, Swedish, Switzerland, theft, thought, thromboinflammation, tie, timeframe, timescale, tract, traditional, translational, UKRI, undertaken, unemployment, unenforceable, unvaried, vendor, viability, virtual, virtually, vivo, wAIHA, whichever, widespread, worsening, Zealand, Zika
Removed: accelerated, accident, calendar, Cantor, delisted, delisting, Duliege, electrical, feedback, grace, IgA, regain, unvested